Therefore, in vivo time-series FMT imaging to measure the iRFP fluorescence of nude mice with orthotopic glioma was conducted in order to objectively assess the effect of tk-VLP/GCV gene therapy on the tumors. This evidence concerns the gene TKT and central nervous system cancer.